Cargando…
Does the WHO 2010 classification of pancreatic neuroendocrine neoplasms accurately characterize pancreatic neuroendocrine carcinomas?
BACKGROUND: The WHO classified pancreatic neuroendocrine neoplasms in 2010 as G1, G2, and neuroendocrine carcinoma (NEC), according to the Ki67 labeling index (LI). However, the clinical behavior of NEC is still not fully studied. We aimed to clarify the clinicopathological and molecular characteris...
Autores principales: | Hijioka, Susumu, Hosoda, Waki, Mizuno, Nobumasa, Hara, Kazuo, Imaoka, Hiroshi, Bhatia, Vikram, Mekky, Mohamed A., Tajika, Masahiro, Tanaka, Tsutomu, Ishihara, Makoto, Yogi, Tatsuji, Tsutumi, Hideharu, Fujiyoshi, Toshihisa, Sato, Takamitsu, Hieda, Nobuhiro, Yoshida, Tsukasa, Okuno, Nozomi, Shimizu, Yasuhiro, Yatabe, Yasushi, Niwa, Yasumasa, Yamao, Kenji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653242/ https://www.ncbi.nlm.nih.gov/pubmed/25142799 http://dx.doi.org/10.1007/s00535-014-0987-2 |
Ejemplares similares
-
Diagnostic performance and factors influencing the accuracy of EUS-FNA of pancreatic neuroendocrine neoplasms
por: Hijioka, Susumu, et al.
Publicado: (2016) -
JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis
por: Ito, Tetsuhide, et al.
Publicado: (2021) -
Mass Spectrometry-Based (GeLC-MS/MS) Comparative Proteomic Analysis of Endoscopically (ePFT) Collected Pancreatic and Gastroduodenal Fluids
por: Paulo, Joao A, et al.
Publicado: (2012) -
Dramatic Survival Benefit Related to R0 Resection of Pancreatic Adenocarcinoma in Patients With Tumor ≤25 mm in Size and ≤1 Involved Lymph Nodes
por: Tummala, Pavan, et al.
Publicado: (2013) -
A Pilot Study to Develop a Diagnostic Test for Pancreatic Ductal Adenocarcinoma Based on Differential Expression of Select miRNA in Plasma and Bile
por: Cote, Gregory A, et al.
Publicado: (2014)